A Phase 1b, Open-Label Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-64264681 in Combination with JNJ-67856633 in Participants with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512687-66-00

Acronym

64264681LYM1002

Enrollment

Registered

2024-08-20

Start date

2021-02-16

Completion date

2025-01-15

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-Hodgkin lymphoma and chronic lymphocytic leukemia

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Poland

None listed

Source: EU CTIS · Data processed: Feb 4, 2026